Patents Assigned to emp Biotech GmbH
  • Patent number: 11731107
    Abstract: A system and method of applied radial technology chromatography using a plurality of beads is disclosed, with each bead comprising one or more pores therein having a diameter of about 250 ? to about 5000 ?, and each bead having an average radius between about 100 ?m to about 250 ?m. Also disclosed are processes for selecting beads for use in a radial flow chromatography column, and for purifying an unclarified feed stream using a radial flow chromatography column.
    Type: Grant
    Filed: April 7, 2022
    Date of Patent: August 22, 2023
    Assignee: emp Biotech GmbH
    Inventors: Alistair J. Hurst, Derek W. K. Levison
  • Patent number: 11325104
    Abstract: A system and method of applied radial technology chromatography using a plurality of beads is disclosed, with each bead comprising one or more pores therein having a diameter of about 250 ? to about 5000 ?, and each bead having an average radius between about 100 ?m to about 250 ?m. Also disclosed are processes for selecting beads for use in a radial flow chromatography column, and for purifying an unclarified feed stream using a radial flow chromatography column.
    Type: Grant
    Filed: December 7, 2018
    Date of Patent: May 10, 2022
    Assignee: EMP BIOTECH GMBH
    Inventors: Alistair J. Hurst, Derek W. K. Levison
  • Publication number: 20080113380
    Abstract: The invention provides methods for detecting an analyte in a sample including the steps of: (a) exciting a sensitizer label on an analyte; (b) permitting energy from the excited sensitizer label to be transferred to and excite an acceptor molecule, whereby the sensitizer label returns to an unexcited state; (c) reacting the excited acceptor molecule with a chemiluminescent precursor to form a chemiluminescent compound which emits light in response to an activation source; (d) exposing the chemiluminescent compound to the activating source to produce a detectable signal; (e) detecting the signal; and (f) correlating the signal with the presence or absence of the analyte. The chemiluminescent precursor is desirably an olefin capable of being converted to a 1,2-dioxetane. Target amplification techniques, such as PCR, may be used to directly label a target analyte with a sensitizer.
    Type: Application
    Filed: January 18, 2008
    Publication date: May 15, 2008
    Applicant: EMP BIOTECH GMBH
    Inventors: Derek Levison, Uwe Moller, Stuart Levison
  • Patent number: 6911305
    Abstract: The invention provides chemiluminescent assays that incorporate a film including at least one chemiluminescent precursor immobilized therewith which produces a triggerable chemiluminescent compound, the film being free of compounds which generate singlet oxygen and being adapted for use with a sensitizer-labeled agent or agent probative of the analyte.
    Type: Grant
    Filed: March 30, 2004
    Date of Patent: June 28, 2005
    Assignee: emp Biotech GmbH
    Inventors: Derek W. K. Levison, Uwe Moller, Stuart Levison
  • Publication number: 20050074815
    Abstract: The invention provides chemiluminescent assays that incorporate a film including at least one chemiluminescent precursor immobilized therewith which produces a triggerable chemiluminescent compound, the film being free of compounds which generate singlet oxygen and being adapted for use with a sensitizer-labeled agent or agent probative of the analyte.
    Type: Application
    Filed: March 30, 2004
    Publication date: April 7, 2005
    Applicant: emp Biotech GmbH
    Inventors: Derek Levison, Uwe Moller, Stuart Levison
  • Patent number: 6764819
    Abstract: The invention provides chemiluminescent assays that incorporate a film including at least one chemiluminescent precursor immobilized therewith which produces a triggerable chemiluminescent compound, the film being free of compounds which generate singlet oxygen and being adapted for use with a sensitizer-labeled agent or agent probative of the analyte.
    Type: Grant
    Filed: July 16, 2002
    Date of Patent: July 20, 2004
    Assignee: emp Biotech GmbH
    Inventors: Derek W. K. Levison, Uwe Moller, Stuart Levison
  • Publication number: 20040014043
    Abstract: The invention provides methods for detecting an analyte in a sample including the steps of: (a) exciting a sensitizer label on an analyte; (b) permitting energy from the excited sensitizer label to be transferred to and excite an acceptor molecule, whereby the sensitizer label returns to an unexcited state; (c) reacting the excited acceptor molecule with a chemiluminescent precursor to form a chemiluminescent compound which emits light in response to an activation source; (d) exposing the chemiluminescent compound to the activating source to produce a detectable signal; (e) detecting the signal; and (f) correlating the signal with the presence or absence of the analyte. The chemiluminescent precursor is desirably an olefin capable of being converted to a 1,2-dioxetane. Target amplification techniques, such as PCR, may be used to directly label a target analyte with a sensitizer.
    Type: Application
    Filed: July 16, 2002
    Publication date: January 22, 2004
    Applicant: emp Biotech GmbH
    Inventors: Derek W.K. Levison, Uwe Moller, Stuart Levison
  • Publication number: 20040014200
    Abstract: The invention provides chemiluminescent assays that incorporate a film including at least one chemiluminescent precursor immobilized therewith which produces a triggerable chemiluminescent compound, the film being free of compounds which generate singlet oxygen and being adapted for use with a sensitizer-labeled agent or agent probative of the analyte.
    Type: Application
    Filed: July 16, 2002
    Publication date: January 22, 2004
    Applicant: emp Biotech GmbH.
    Inventors: Derek W.K. Levison, Uwe Moller, Stuart Levison
  • Patent number: 6613578
    Abstract: The present invention relates to chemiluminescent assays which incorporate a second film or membrane which includes a solid chemical component for activation of a stable dioxetane. Decomposition of the stable dioxetane can be accomplished using a combination of heat and chemical treatment.
    Type: Grant
    Filed: June 4, 2002
    Date of Patent: September 2, 2003
    Assignee: EMP Biotech GmbH
    Inventors: Uwe Moller, Derek Levison, Stuart Levison